During neocortical development, neurons are produced by a diverse pool of neural progenitors. A subset 57 of progenitors express the Cux2 gene and are fate-restricted to produce certain neuronal subtypes, but 58 the upstream pathways that specify these progenitor fates remain unknown. To uncover the 59 transcriptional networks that regulate Cux2 expression in the forebrain, we characterized a conserved 60
During forebrain development, neural progenitor cells give rise to many different types of neuronal and 72 glial cells that form the various telencephalic structures and circuits. This vast cellular diversity arises 73 through the interplay between early tissue patterning pathways and gene regulatory networks (GRNs). 74
Early in development, multiple tissue organizers and signaling centers provide morphogenic cues that 75 govern regional identity and size. Within these different regions, complex transcriptional programs 76 further diversify multipotent progenitor cells toward specific cell fates. The transcription factors (TFs) 77 that establish the different GRNs to specify cell fates often work by binding gene regulatory elements, 78 such as enhancers, to boost or suppress expression of target genes. Following transcriptional activation 79 of GRNs, neural progenitors divide and eventually differentiate into specified cells. A key to better 80 understanding forebrain development and function is to identify the signaling and transcriptional 81 networks that establish regional identity and subtype fate specification during embryonic development. 82
The TF Cut-like homeobox 2 (Cux2) is dynamically expressed in complex spatiotemporal 83 patterns in the developing mouse forebrain (Zimmer et al., 2004) . During early brain development, a 84 subset of neural progenitors weakly express Cux2 transcripts in a salt and pepper pattern (Franco et al., 85 2012) . We previously fate-mapped the lineage output of Cux2 + progenitors in the neocortex and found 86 that this subset of neural progenitors are fate-restricted to produce late-born corticocortical neurons in 87 upper layers (Franco et al., 2012; Gil-Sanz et al., 2015) . Our studies indicated that Cux2 + progenitors in 88 the developing forebrain are committed to this fate even before the onset of neurogenesis. However, the 89 underlying mechanisms that restrict Cux2 + progenitors to specific cell fates remain largely unknown. 90
Cux2 knockout mice do not display any significant phenotype with respect to progenitor cell fate 91 specification (Cubelos et al., 2008) , implying that Cux2, while a useful marker for a fate-committed 92 progenitor population, does not necessarily instruct fate in this context. We reasoned that a deeper 93 understanding of Cux2 + cell fate commitment in forebrain progenitors could be achieved by uncovering 94 the upstream GRNs responsible for the complex patterns of Cux2 expression. Interestingly, neural 95 progenitors in the dorsal telencephalic midline (DTM) strongly express Cux2 in a more complete pattern 96 than progenitors in adjacent regions, suggesting that this forebrain region might contain critical 97 transcriptional regulators of the Cux2 locus. 98
Previous studies have uncovered enhancers active in the developing mouse telencephalon, 99
including an 856 bp element in intron 2 of the Cux2 genomic locus that could drive strong transgene 100 expression in the DTM (Hasenpusch-Theil et al., 2012; Visel et al., 2008) . Here, we characterized this 101 element as an active enhancer in the developing forebrain and show that it is specifically active in the 102 cortical hem, but not in the adjacent hippocampus or neocortex. We further analyzed this enhancer for 103 possible upstream regulators of Cux2 expression. Among several bioinformatically identified candidates, 104 we tested several transcription factors known to function in or be expressed within the cortical hem. 105
Using an in vitro approach, we demonstrate that Lmx1a is a strong activator of the Cux2 hem-specific 106 enhancer. Additionally, in vivo Lmx1a gain-of-function in the neocortex, a region normally devoid of 107 Lmx1a expression, increased the proportion of Cux2 + cells. Finally, we analyzed other enhancers that 108 exhibit specific activity in the cortical hem and identify recurrent Lmx1a binding sites as a common 109 motif shared between these distinct hem-specific enhancers. Our results suggest Lmx1a functions as an 110 upstream regulator of a conserved Cux2 enhancer in the cortical hem, and raise the possibility that 111
Lmx1a is a critical TF in the GRN that specifies cortical hem fate. 112
113
Results 114
Early forebrain expression of Cux2 begins at the dorsal telencephalic midline 115
To better understand when and where the earliest transcriptional regulators of Cux2 are active in the 116 developing telencephalon, we sought to define the temporal and spatial patterns of Cux2 gene 117 expression. We crossed Cux2 Cre/+ mice to the Ai9 Cre-reporter line and used recombination (tdTomato + ) 118 as a readout of the cumulative transcriptional history of the Cux2 genomic locus. Cux2 Cre/+ ;Ai9 fl/+ brains 119 were analyzed at E9.5, 10.5, 12.5 and 14.5 (Fig 1) . We found that the earliest consistent pattern of 120 recombined cells in the forebrain first appeared in the dorsal telencephalic midline (DTM) at ~ E9.5 121 ( Fig. 1A) . At this age, a few recombined cells also began to appear scattered very sparsely throughout 122 the adjacent neocortical neuroepithelium ( Fig. 1A ). By E10.5, the entire DTM was recombined, and the 123 number of tdTomato + neuroepithelial cells was increased in the neocortex ( Fig. 1B) . At E12.5 and 124 E14.5, the DTM is reorganized to comprise 2 distinct structures: the cortical hem and choroid plexus 125 epithelium (Grove et al., 1998) . Essentially all cells in the cortical hem and choroid plexus were 126 recombined at E12.5 ( Fig. 1C ) and E14.5 (Fig. 1D ). In contrast, only a fraction of cells in the adjacent 127 that specify area and subtype fate in the telencephalon, we sought to identify enhancers that could 137 recapitulate Cux2 expression in the developing forebrain. A previous study identified an 856 base pair 138 (bp) region within the human Cux2 gene (hs611) that exhibits extreme human-rodent sequence 139 conservation, suggesting an important functional role for this non-coding element (Visel et al., 2008) . 140
Indeed, both the human element (Visel et al., 2008) in the developing forebrain, we first cloned the 856 bp murine region into an expression vector (Wilken 150 et al., 2015) with a minimal promoter (TATA box) driving Cre recombinase. We then introduced the 151 plasmid into the developing forebrain of Ai9 Cre-reporter mice at E12.5, using in utero electroporation 152 ( Fig. 3A ). We co-electroporated a plasmid expressing GFP from the ubiquitously-expressed synthetic 153 CAG promoter (Niwa et al., 1991) as a marker of electroporated cells (Fig. 3A ). Electroporations were 154 performed to target different regions of the telencephalon, including the cortical hem, hippocampal 155 primordium, and neocortex. We analyzed patterns of GFP expression and Cre-mediated recombination 156 (tdTomato expression) at E14.5. As controls, we compared recombination patterns in the 157
Cux2Enhancer-Cre electroporations to those of the minimal promoter construct alone (MINp-Cre, no 158 enhancer) or with a strong and ubiquitous promoter (CAG-Cre). We found that recombined tdTomato + 159 cells in the MINp-Cre electroporations were very sparse in the DTM (Fig. 3B ), hippocampus and the 160 neocortex ( Our in silico data predicted multiple binding sites for Emx2 and Lmx1a that overlapped each other (Fig. 194 4B), which correlated well with our in vitro studies demonstrating that these factors can activate the 195
Cux2 enhancer (Fig. 5B ). To directly test whether these putative TF binding sequences were required for 196 enhancer activation, we generated a mutant enhancer construct in which the central 8 base pairs of the 197 predicted binding sites were mutated ( Fig. 5C ) and the mutant Cux2Enhancer-mCherry plasmid was 198 tested for activation by Emx2 and Lmx1a. In contrast to the wild-type Cux2 enhancer, the mutated 199 version was no longer activated by Lmx1a ( Fig. 5C) . Surprisingly, Emx2 was still able to upregulate 200 expression from the mutated enhancer ( Fig. 5C ), raising the possibility of other more critical Emx2 201 binding sites within the enhancer. 202
We next tested the activity of the mutated enhancer in vivo by in utero electroporation of the 203 mutated enhancer driving Cre recombinase into Ai9 reporter embryos ( Fig. 6A ). As we observed 204 previously, the wild-type Cux2-Enhancer-Cre drove recombination specifically and robustly in the 205 cortical hem (Fig. 6B ). In contrast, the TF binding site mutant Cux2-Enhancer-Cre construct was unable 206 to drive any recombination at all in the cortical hem ( Fig. 6C ). Together with our in vitro studies, these 207 cortical hem and hippocampus is very similar to that of Cux2 (Fig. 7A ), which is expressed strongly 217 throughout the cortical hem but only weakly in a limited number of progenitors and neurons in the 218 hippocampus and neocortex ( Fig. 1 ). Since Lmx1a is not expressed at all in the developing neocortex 219
where Cux2 expression is initially weak, this provided us an opportunity to assess whether mis-220 expression of Lmx1a in the neocortex is sufficient to upregulate endogenous Cux2 expression. To test 221 this possibility, we electroporated our CAG-Lmx1a-IRES-GFP construct into the neocortex of Cux2 Cre/+ ; 222
Ai9 fl/+ embryos in utero at E12.5 ( Fig. 7B ). We allowed the embryos to continue developing until E14.5 223 and analyzed the percentage of electroporated cells (GFP + ) that belonged to the Cux2 lineage 224 (tdTomato + ). Compared to the CAG-IRES-GFP control ( Fig. 7C-D) , Lmx1a mis-expression resulted in a 225 statistically significant (p = 0.0001) 2-fold increase in tdTomato + cells within the electroporated 226 population ( Fig. 7E-G) . These data support a role for Lmx1a in promoting endogenous Cux2 expression 227 in the early developing telencephalon. Emx2 and Lmx1a binding sites overlapped each other, reflective of the similarity of their consensus 300 binding motifs. Interestingly, mutation of several of these putative binding sites drastically reduced 301 responsiveness of the enhancer to Lmx1a, but not to Emx2. This may suggest substantial redundancy in 302 the Emx2 binding sites in the Cux2 enhancer, or that the remaining Emx2 binding sites are more critical. 303 Importantly, the mutated enhancer showed no activity in the cortical hem, suggesting that binding of 304
Lmx1a, but not Emx2, is critical for enhancer activation in vivo. This would be in line with our further 305 experiments showing that the Cux2 enhancer is not active in the neocortex, where Emx2 is strongly 306 expressed but Lmx1a is absent. 307
In further support of Lmx1a as an activator of Cux2 expression, we found that mis-expressing 308 Lmx1a in the neocortex results in an increase in Cux2 + cells. Although this assay does not allow us to 309 determine whether the increase results from direct activation of the cortical hem enhancer, our data point 310 to Lmx1a as being sufficient to activate Cux2 expression in the developing forebrain. Interestingly, 311
Lmx1a mis-expression in the neocortex did not drive recombination in all cells in the electorporated 312 region, in contrast to the complete recombination pattern seen in the cortical hem of Cux2-Cre mice. 313
This result could simply be due to insufficent levels or duration of Lmx1a expression, or it may suggest 314 the presence of additional factors that regulate Cux2 expression. For example, Lmx1a may require a 315 transcriptional co-activator for maximum activity that is missing from the neocortex, or perhaps there is 316 an unidentified transcriptional repressor of the Cux2 enhancer that is expressed specifically in the 317 neocortex. Further studies will be required to fully elucidate the mechanisms that control the complex 318 expression pattern of Cux2 in the developing forebrain. 319
Lmx1a as a common activator of cortical hem GRNs 321
When we compared the murine and human Cux2 enhancers to two other conserved human elements that 322 drive expression in the cortical hem, we found that the Additionally, Cux2 expression appears coincident with BMP4 within the mesenchyme of the developing 338 mouse limb bud (Iulianella et al., 2003) . How BMPs activate Cux2 expression in these contexts has not 339 been determined, but it would be interesting to test whether BMP signaling can drive Cux2 expression in 340 multiple tissues through Lmx1a-mediated activation of the conserved enhancer. 341 342
Conclusions 343
In this study we identify a conserved enhancer and its transcriptional activator, Lmx1a, as an 344 important mechanism for driving restricted expression of Cux2 in the developing forebrain. We further 345
show that recurrent Lmx1a binding sites are a common motif shared in multiple enhancers with 346 similarly restricted activities. These studies provide a template for future studies aimed at identifying 347 other Cux2 cis-regulatory elements that control its complex expression during forebrain development, 348 and the ultimately the upstream GRNs that specify different cell fates among the forebrain progenitor (Hand et al., 2005) , between the CAG promoter and the IRES-GFP cassette. In utero 367 electroporation of plasmids (0.5-1mg/ml) were carried out as previously described (Franco et al., 2012; 368 Gil-Sanz et al., 2013) on E12.5 embryos of timed-pregnant mice. Embryos were harvested for analysis 369 at E14.5. 370
Immunohistochemistry. Brains from E9.5-14.5 embryos were dissected and fixed for 2 hours at room 371 temperature in 4% paraformaldehyde. Forebrains were sectioned on a vibrating microtome (Leica 372 VT1200S) at 100 µm increments, or on a cryostat (Leica CM1520) at 15-30 µm increments. 373
Immunohistochemistry was performed on tissue sections as described previously ( 
